US Patent 10336744 1AP E3 ligase directed proteolysis targeting chimeric molecules
Patent 10336744 was granted and assigned to GlaxoSmithKline on July, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10336744 1AP E3 ligase directed proteolysis targeting chimeric molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
